NCT07494565
- Conditions
- CD5 Positive, Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,644 public trials
847 recruiting studies
Lymphoma trial results
NCT06742996
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- Ucsf Fresno Fresno, California, United States
- Kaiser Permanente Southern California Irvine, California, United States
NCT06542250
- Conditions
- B-cell Malignancies, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Boston, Massachusetts, United States
- Research Site Rochester, Minnesota, United States
- Research Site Hackensack, New Jersey, United States
NCT07154823
- Conditions
- Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL), Hematologic Diseases, +15 more
- Locations
-
- University of Iowa Hospital and Clinics Iowa City, Iowa, United States
- The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
- Washington University in St. Louis St Louis, Missouri, United States
- Cancer Care Specialists of Reno Reno, Nevada, United States
NCT07101705
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT07205315
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +31 more
- Locations
-
- Zhengzhou Yihe Hospital Zhengzhou, Henan, China
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Recruiting
Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA
NCT07620314
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
Recruiting
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
NCT07409428
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Baoding NO.1 Central Hospital Baoding, China
- Beijing GoBroad Hospital Beijing, China
- BEIJING TONGREN HOSPITAL, Capital Medical University Beijing, China
- Conditions
- B-Cell Non-Hodgkins Lymphoma, Cytokine Release Syndrome, Disease Attributes, +17 more
- Locations
-
- Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
- Community Cancer Institute (CCI) Clovis, California, United States
- Providence Medical Foundation Fullerton, California, United States
- Los Angeles Cancer Network Glendale, California, United States
NCT06863402
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States